Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Sirolimus for Epidermal Nevi
NCT07813533Phase 1Not yet recruiting
- Sponsor
- Northwestern University
- Start
- Oct 2026
- Primary completion
- Sep 2028
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of sirolimus in epidermal nevus, sponsored by Northwestern University. Primary endpoint: Improvement of nevi flattening and normalization of skin color at 12 weeks. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
sirolimus
03
Conditions
epidermal nevus
Beyond the preview
Go deeper on NCT07813533.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07813533.